Acatechol, Inc.
Pasadena, CA Doing business as Acatechol Inc.
- UEI
- H1J2E88TYBN5
- CAGE
- 8GF98
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2265 E Foothill Blvd, Pasadena, CA 91107, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| DHA sbir PH i topic DHA242-003, proposal H242-003-0066 titled "bioinspired chitosan-based hydrogels for… | Defense Health Agency | $250,000 | |
| Sbir phase i: anti-infective foley catheters for long-term prevention of catheter-associated urinary tract infections… | National Science Foundation | $274,982 | |
| High-performance antibiofilm central venous catheters for prevention of central line associated bloodstream infections -… | National Institute of Allergy and Infectious Diseases | $1,000,000 | |
| Hybrid repellant-antimicrobial gemini coatings for prevention of catheter-associated bloodstream infections - project… | National Institute of Allergy and Infectious Diseases | $1,258,940 | |
| Sbir phase i: virucidal surface coatings for prevention of covid-19 transmission | Division of Industrial Innovation | $275,864 |
About Acatechol, Inc.
Acatechol, Inc. is a minority-owned, for-profit corporate entity specializing in innovative anti-infective coatings and surface technologies for medical devices. Based in Pasadena, California, the company is registered in SAM.gov through February 2026 and focuses on developing advanced technological solutions for medical applications. The company provides specialized research and development services to federal agencies, with a particular emphasis on creating novel biomaterial and surface coating technologies that address critical healthcare challenges.
In its federal contract work, Acatechol, Inc. has been awarded a Small Business Innovation Research (SBIR) Phase I contract from the Defense Health Agency (DHA) valued at $249,999.84. The contract, set aside for small businesses, involves developing a bioinspired chitosan-based hydrogel for neuroprotective treatment of traumatic brain injury. The research project is expected to be completed by October 2, 2025, and represents the company's capability to engage in advanced medical research and development for federal defense health initiatives.
Regarding federal grant awards, Acatechol, Inc. has received multiple grants from agencies like the National Science Foundation (NSF) and the National Institute of Allergy and Infectious Diseases. These grants focus on developing innovative anti-infective coatings for medical devices, including Foley catheters and central venous catheters. Specific grant projects include a $274,982 NSF SBIR Phase I grant to develop an anti-infective coating for Foley catheters to prevent catheter-associated urinary tract infections, and an NIH grant (R43AI177051) aimed at creating hybrid repellant-antimicrobial coatings to prevent central line-associated bloodstream infections. The company has also performed sub-grant work with institutions like Columbia University, demonstrating its collaborative research capabilities in developing advanced medical technologies.
Quick answers
What is Acatechol, Inc.'s UEI?
Acatechol, Inc.'s Unique Entity ID (UEI) in SAM.gov is H1J2E88TYBN5.
What is Acatechol, Inc.'s CAGE code?
Acatechol, Inc.'s CAGE code is 8GF98.
What is Acatechol, Inc.'s primary NAICS code?
Acatechol, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Acatechol, Inc. located?
Acatechol, Inc.'s physical address in SAM.gov is 2265 E Foothill Blvd, Pasadena, CA 91107, USA.
Is Acatechol, Inc. registered in SAM.gov?
Yes. Acatechol, Inc.'s SAM.gov registration is active through January 14, 2027.
What is Acatechol, Inc.'s most recent federal award?
Acatechol, Inc.'s most recent federal contract award is DHA sbir PH i topic DHA242-003, proposal H242-003-0066 titled "bioinspired chitosan-based hydrogels for… (HT942525P0036), from Defense Health Agency, on March 3, 2025.
On GovTribe
See Acatechol, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors